Logo
Chat on WhatsApp

CDSCO License for Cardiopulmonary bypass cardiotomy suction line blood

Medical Device Information

Device Class
Class B

Intended Use

A cardiopulmonary bypass cardiotomy suction line blood filter is a device used as part of a gas exchange (oxygenator) system to filter nonbiologic particles and emboli (a blood clot or a piece of foreign material flowing in the bloodstream which will obstruct circulation by blocking a vessel) out of the blood. This device is intended for use in the cardiotomy suction line.

Manufacturing License
MD5
Import License
MD15
CDSCO License for Cardiopulmonary bypass cardiotomy suction line blood

Comprehensive Guide to CDSCO Licensing for Cardiopulmonary Bypass Cardiotomy Suction Line Blood Filters

As seasoned regulatory consultants with over 25 years of experience and having supported more than 500 companies in gaining CDSCO approvals, we understand the intricacies involved in navigating India’s medical device regulatory landscape. The cardiopulmonary bypass cardiotomy suction line blood filter is a Class B cardiovascular device designed to filter non-biologic particles and emboli from blood during cardiopulmonary bypass surgeries. Given its critical role, securing the appropriate CDSCO license is essential to legally manufacture or import this device into the Indian market.

CDSCO Regulatory Framework for Cardiopulmonary Bypass Cardiotomy Suction Line Blood Filters

In India, medical devices are regulated under the Medical Device Rules (MDR) 2017, overseen by the Central Drugs Standard Control Organization (CDSCO). This device falls under the cardiovascular category, classified as Class B based on its moderate risk profile. As per the notification 29/Misc./03/2020-DC (159) dated 26.07.2021, it is mandated that manufacturers obtain an MD5 license granted by the State Licensing Authority.

Risk Classification and License Requirements

Class B devices such as the cardiotomy suction line blood filter require an MD5 manufacturing license (Application Form MD3). This is a state-level license involving a series of steps including obtaining a test license, product testing, document submission, and audit by a notified body. Importers must secure an MD15 import license from the Central Licensing Authority.

Manufacturing License Process (MD5)

The end-to-end process to obtain an MD5 license generally spans 3 to 4 months. The key stages include:

  1. Test License (Form MD13): Initially, the manufacturer must apply for a test license to conduct product testing. This usually takes 1.5 to 2 months.

  2. Product Testing: The device samples must be tested at CDSCO-approved government laboratories. Refer to the list of testing laboratories for accredited facilities.

  3. Document Preparation: Compile comprehensive documentation including technical files, quality management system (QMS) evidence, and labeling details.

  4. Application Submission: Submit the MD5 license application (Form MD3) through the CDSCO MD Online Portal along with applicable fees.

  5. Audit by Notified Body: An audit is carried out by a notified body listed on the CDSCO Notified Bodies list to verify compliance with MDR.

  6. Query Resolution: Respond promptly to any queries raised by the licensing authority or notified body.

  7. License Grant: Upon satisfactory review, the MD5 license is issued on Form MD5, authorizing manufacturing.

Manufacturing License Documents Required

For a Class B cardiovascular device such as this, the following documents must be meticulously prepared:

  • Company Constitution (Incorporation Certificate, GST Registration)
  • Proof of Ownership or Lease Agreement of Manufacturing Premises
  • Technical Staff Qualification and Experience Documents
  • Fire No Objection Certificate (NOC)
  • Pollution Control Board Clearance
  • Device Master File (DMF) detailing design, specifications, and manufacturing process (Device Master File Guide)
  • Plant Master File (PMF) describing infrastructure and quality controls (Plant Master File Guide)
  • Essential Principles Compliance Checklist
  • Risk Management File demonstrating hazard analysis and mitigation (Risk Management)
  • Product Test Reports from CDSCO-approved labs
  • Labels and Instructions for Use (IFU) complying with MDR requirements
  • Quality Management System Documentation (ISO 13485 certification strongly recommended)

Import License Process (MD15)

For importers of cardiopulmonary bypass cardiotomy suction line blood filters, the MD15 license issued by the Central Licensing Authority is mandatory. The process typically takes 5 to 6 months and involves:

  • Preparation of documents including manufacturing license of the exporter, Free Sale Certificate, ISO 13485:2016, CE Certificate if applicable, Device and Plant Master Files, and wholesale license
  • Submission of application on the CDSCO MD Online Portal using Form MD14
  • Resolution of departmental queries
  • Grant of MD15 import license on Form MD15

Refer to our detailed Import License Guide for stepwise instructions.

Timeline and Processing Duration

License TypeProcess StepsTimeframe
MD5 ManufacturingTest License + Testing + Application + Audit3 to 4 months
MD15 ImportDocument Preparation + Application + Review5 to 6 months

Timely submission of complete and accurate documents is critical to avoid delays.

Government Fees and Costs

  • MD5 License: Rs 5,000/- per application plus Rs 500/- per product
  • Test License (MD13): Included within MD5 process
  • MD15 Import License:
    • Class B devices attract fees of Rs 2,000/- per site and Rs 1,000/- per product

Note: Fees are subject to change; always verify current rates on the CDSCO portal.

Common Challenges and Solutions

  • Incomplete Documentation: Many applicants face delays due to missing or poorly prepared files. We recommend using comprehensive checklists and templates to ensure all documentation is in order.

  • Delayed Product Testing: Coordinate early with notified testing laboratories to schedule and complete tests promptly.

  • Audit Non-Compliance: Engage with experienced notified bodies familiar with cardiovascular devices for smoother audits.

  • Query Management: Respond to CDSCO queries within stipulated time frames with clear, evidence-backed replies to avoid lengthy back-and-forth.

Expert Consultation and Support

Navigating CDSCO licensing for a specialized device like the cardiopulmonary bypass cardiotomy suction line blood filter requires in-depth knowledge of regulatory nuances. Our consultancy offers:

  • Gap assessments for existing documentation
  • Assistance with Device and Plant Master Files
  • Coordination with notified bodies and testing labs
  • End-to-end application management on the CDSCO MD Online Portal
  • Post-license compliance and renewals

Getting Started with Your CDSCO License Application

If you are a manufacturer or importer ready to enter the Indian market with this Class B cardiovascular device, here are actionable next steps:

  1. Assess Your Device Classification: Confirm your device class on the Medical Device Classification guide.

  2. Initiate Test License Application: Apply for the MD13 test license early to begin product testing.

  3. Prepare Robust Documentation: Start compiling your Device Master File, Plant Master File, and Risk Management File.

  4. Engage a Notified Body: Select an appropriate notified body from the CDSCO Notified Bodies list to schedule your audit.

  5. Submit Application Online: Use the CDSCO MD Online Portal for all submissions.

  6. Plan for Post-License Compliance: Establish your QMS to maintain ongoing regulatory compliance.

Our dedicated team is ready to guide you through each stage, ensuring your cardiopulmonary bypass cardiotomy suction line blood filter meets all CDSCO requirements swiftly and efficiently. Contact us to begin your application journey with confidence.

Get Expert Help

Free consultation for your medical device license

24/7 Support Available

Why Choose Us

500+ Licenses Obtained
100% Success Rate
15+ Years Experience
24/7 Support Available

About the Author

avatar
Tails Azimuth
@Twitter